Pzena Investment Management LLC lowered its holdings in Koninklijke Philips (NYSE:PHG – Free Report) by 5.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,013 shares of the technology company’s stock after selling 724 shares during the quarter. Pzena Investment Management LLC’s holdings in Koninklijke Philips were worth $426,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Allspring Global Investments Holdings LLC acquired a new position in shares of Koninklijke Philips in the 1st quarter valued at $40,000. Fairscale Capital LLC purchased a new stake in shares of Koninklijke Philips during the 2nd quarter worth about $54,000. CWM LLC grew its position in shares of Koninklijke Philips by 21.9% during the 2nd quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after acquiring an additional 616 shares during the period. Eastern Bank acquired a new stake in shares of Koninklijke Philips during the 3rd quarter valued at about $88,000. Finally, Blue Trust Inc. raised its holdings in Koninklijke Philips by 902.7% in the 2nd quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock worth $93,000 after purchasing an additional 3,331 shares during the period. Institutional investors and hedge funds own 13.67% of the company’s stock.
Koninklijke Philips Price Performance
NYSE:PHG opened at $26.31 on Thursday. The stock has a 50 day moving average of $29.81 and a two-hundred day moving average of $28.27. Koninklijke Philips has a 12 month low of $19.49 and a 12 month high of $32.91. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Koninklijke Philips
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- EV Stocks and How to Profit from Them
- Williams-Sonoma Stock: Buy It and Never Let It Go
- About the Markup Calculator
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.